Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Nature Communications|June 21, 2022
Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronavirusesZepeng Xu, Xinrui Kang, Pu Han, et al.Endocrine Journal|March 24, 2022
Urolithin A ameliorates diabetic retinopathy via activation of the Nrf2/HO-1 pathwayZepeng Xu, Songtao Li, Kunmeng Li, et al.International Journal of Biological Sciences|July 25, 2022
Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2Lingfeng Tang, Di Zhang, Pu Han, et al.The EMBO Journal|March 12, 2024
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteinsWeiwei Li, Zepeng Xu, Tianhui Niu, et al.Cell Reports. Medicine|April 5, 2023
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBBQingwen He, Lili Wu, Zepeng Xu, et al.Med (New York, N.Y.)|April 4, 2024
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodiesQingwen He, Yaling An, Xuemei Zhou, et al.The EMBO Journal|December 15, 2022
Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologsYu Hu, Kefang Liu, Pu Han, et al.Structure (London, England : 1993)|July 16, 2024
Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variantsLinjie Li, Kaiyuan Shi, Yuhang Gu, et al.Plos Pathogens|September 18, 2023
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7Yanfang Zhang, Xinrui Kang, Sheng Liu, et al.Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.Pageof 5